Dr. Christine Ren-Fielding, Chief of Bariatric Surgery at NYU Langone Health, discusses the future of weight loss approaches. She delves into the impact of GLP-1 medications like Ozempic, questioning if they could replace traditional bariatric surgery. The conversation covers the intricate relationship between set point theory, food addiction, and psychological factors affecting weight loss. Dr. Ren-Fielding also shares insights on the success rates of surgery and patient experiences, shedding light on societal perceptions and common misconceptions surrounding obesity treatment.